These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 12894845)
1. Biology and clinical impact of human natural killer cells. Farag SS; VanDeusen JB; Fehniger TA; Caligiuri MA Int J Hematol; 2003 Jul; 78(1):7-17. PubMed ID: 12894845 [TBL] [Abstract][Full Text] [Related]
2. Immunologic approaches to acute leukemia in the elderly. Farag SS; Caligiuri MA Semin Hematol; 2006 Apr; 43(2):118-25. PubMed ID: 16616045 [TBL] [Abstract][Full Text] [Related]
3. Human natural killer cell development and biology. Farag SS; Caligiuri MA Blood Rev; 2006 May; 20(3):123-37. PubMed ID: 16364519 [TBL] [Abstract][Full Text] [Related]
4. New directions in natural killer cell-based immunotherapy of human cancer. Farag SS; Fehniger TA; Becknell B; Blaser BW; Caligiuri MA Expert Opin Biol Ther; 2003 Apr; 3(2):237-50. PubMed ID: 12662139 [TBL] [Abstract][Full Text] [Related]
5. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
6. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
7. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer. Arina A; Murillo O; Dubrot J; Azpilikueta A; Alfaro C; Pérez-Gracia JL; Bendandi M; Palencia B; Hervás-Stubbs S; Melero I Expert Opin Biol Ther; 2007 May; 7(5):599-615. PubMed ID: 17477799 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Farag SS; Fehniger TA; Ruggeri L; Velardi A; Caligiuri MA Blood; 2002 Sep; 100(6):1935-47. PubMed ID: 12200350 [TBL] [Abstract][Full Text] [Related]
11. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology. Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457 [TBL] [Abstract][Full Text] [Related]
12. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
14. Natural killer lymphocytes: "null cells" no more. Moretta A; Bottino C; Sivori S; Marcenaro E; Castriconi R; Della Chiesa M; Carlomagno S; Augugliaro R; Nanni M; Vitale M; Millo R Ital J Anat Embryol; 2001; 106(4):335-42. PubMed ID: 12003235 [TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. Goodier MR; Londei M J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046 [TBL] [Abstract][Full Text] [Related]
16. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. Moretta L; Moretta A EMBO J; 2004 Jan; 23(2):255-9. PubMed ID: 14685277 [TBL] [Abstract][Full Text] [Related]
17. NK cell receptors as tools in cancer immunotherapy. Sentman CL; Barber MA; Barber A; Zhang T Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660 [TBL] [Abstract][Full Text] [Related]
18. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240 [TBL] [Abstract][Full Text] [Related]